ArticleJournal of molecular medicine (Berlin, Germany)2018

Dual immuno-renal targeting of 7-benzylidenenaltrexone alleviates lupus nephritis via FcγRIIB and HO-1.

Tsung-Chih Tseng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.